Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Browse the full article librarySame molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Different molecules: Ozempic is semaglutide (GLP-1 only); Mounjaro is tirzepatide (GLP-1 + GIP). Mounjaro tends to deliver more weight loss in head-to-head data.
Different molecules: Ozempic is semaglutide (GLP-1 only); Mounjaro is tirzepatide (GLP-1 + GIP). Mounjaro tends to deliver more weight loss in head-to-head data.
